No. of Pages: 181 | Report Code: TIPRE00009258 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Colorectal Cancer Market – By Modality
1.3.2 Europe Colorectal Cancer Market – By End User
1.3.3 Europe Colorectal Cancer Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 New Product Launches
5.1.3 Benefits Offered by Generic Drugs
5.2 Market Restraints
5.2.1 Pricing Pressure on Drug Manufacturers
5.3 Future Trends
5.3.1 Shift Toward Personalized Medicine
5.4 Impact Analysis
6.1 Europe Colorectal Cancer Market Revenue Forecast and Analysis
7.1 Overview
7.2 Europe Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
7.3 Diagnosis Type
7.3.1 Overview
7.3.2 Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Immunohistochemistry
7.3.3.1 Overview
7.3.3.2 Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Stool Test
7.3.4.1 Overview
7.3.4.2 Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Flexible Sigmoidoscopy
7.3.5.1 Overview
7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Colonoscopy
7.3.6.1 Overview
7.3.6.2 Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 CEA Test
7.3.7.1 Overview
7.3.7.2 CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Other Test
7.3.8.1 Overview
7.3.8.2 Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Therapy Type
7.4.1 Overview
7.4.2 Europe Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Chemotherapy
7.4.3.1 Overview
7.4.3.2 Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.3 Alkylating Agent
7.4.3.3.1 Overview
7.4.3.3.2 Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.4 Antimetabolites
7.4.3.4.1 Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.5 Others
7.4.3.5.1 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Immunotherapy
7.4.4.1 Overview
7.4.4.2 Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.3 Panitumumab
7.4.4.3.1 Overview
7.4.4.3.2 Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.4 Cetuximab
7.4.4.4.1 Overview
7.4.4.4.2 Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.5 Bevacizumab
7.4.4.5.1 Overview
7.4.4.5.2 Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.6 Others
7.4.4.6.1 Overview
7.4.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Chemoprotectant
7.4.5.1 Overview
7.4.5.2 Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging Type
7.5.1 Overview
7.5.2 Europe Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Computed Tomography (CT)
7.5.3.1 Overview
7.5.3.2 Computed Tomography (CT) : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Magnetic Resonance Imaging (MRI)
7.5.4.1 Overview
7.5.4.2 Magnetic Resonance Imaging (MRI) : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others
7.5.5.1 Overview
7.5.5.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
8.1 Overview
8.2 Europe Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic and Research Laboratories
8.4.1 Overview
8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1 Overview
9.1.1 Europe: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
9.1.1.1 Germany: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Germany: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.2 Germany: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.1.2.1 Germany: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.1.2.2 Germany: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.1.2.2.1 Germany: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.1.2.2.2 Germany: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.1.2.3 Germany: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.1.3 Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.2 France: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 France: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.2 France: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.2.2.1 France: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.2.2.2 France: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.2.2.2.1 France: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.2.2.2.2 France: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.2.2.3 France: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.2.3 France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.3 UK: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 UK: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.2 UK: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.3.2.1 UK: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.3.2.2 UK: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.3.2.2.1 UK: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.3.2.2.2 UK: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.3.2.3 UK: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.3.3 UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.4 Italy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.1 Italy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.2 Italy: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.4.2.1 Italy: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.4.2.2 Italy: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.4.2.2.1 Italy: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.4.2.2.2 Italy: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.4.2.3 Italy: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.4.3 Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.5 Spain: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.1 Spain: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.2 Spain: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.5.2.1 Spain: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.5.2.2 Spain: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.5.2.2.1 Spain: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.5.2.2.2 Spain: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.5.2.2 Spain: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.5.3 Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.6 Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.1 Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.2 Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.6.2.1 Rest of Europe: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.6.2.2 Rest of Europe: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.6.2.2.1 Rest of Europe: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.6.2.2.2 Rest of Europe: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.6.2.3 Rest of Europe: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.6.3 Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
10.1 Overview
10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.4 Inorganic Developments
10.4.1 Overview
10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028
11.1 Epigenomics AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Novigenix SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Amgen Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 F. HOFFMANN-LA ROCHE LTD.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Bruker Corporation
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Quest Diagnostics Incorporated
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 EDP Biotech Corporation
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Volitionrx Limited
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12.1 About The Insight Partners
12.2 Glossary of Terms
Table 1. Germany: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 2. Germany: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 8. France: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 9. France: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 13. France: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 15. UK: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 16. UK: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. UK: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. UK: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 22. Italy: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 23. Italy: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 29. Spain: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 30. Spain: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Spain: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 33. Spain: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 34. Spain: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 35. Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 36. Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 37. Rest of Europe: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. Rest of Europe: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 39. Rest of Europe: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 40. Rest of Europe: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 43. Recent Organic Growth Strategies In The Colorectal Cancer Market
Table 44. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
Table 45. Glossary of Terms, Europe Colorectal Cancer Market
Figure 1. Europe Colorectal Cancer Market Segmentation
Figure 2. Europe Colorectal Cancer Segmentation, By Country
Figure 3. Europe Colorectal Cancer Market Overview
Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In Europe Colorectal Cancer Market
Figure 5. Rest of Europe is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Europe Colorectal Cancer Market - PEST Analysis
Figure 7. Comparison of Branded Drugs and Generic Drugs
Figure 8. Europe Colorectal Cancer Market Impact Analysis of Drivers And Restraints
Figure 9. Europe Colorectal Cancer Market – Revenue Forecasts And Analysis – 2019- 2028
Figure 10. Europe Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%)
Figure 11. Europe Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Europe Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Europe Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Europe Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Europe Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%)
Figure 35. Europe Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Europe Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Europe: Colorectal Cancer Market Revenue Overview, by Key Country – Revenue (2022) (US$ Million)
Figure 38. Europe: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
Figure 39. Germany: Colorectal Cancer Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. France: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. UK: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Italy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Spain: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Growth Strategies In The Colorectal Cancer Market, 2022-2028
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Colorectal Cancer Market
